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A survey of smoking cessation training within UK Pharmacy education 
Abstract 
Introduction: Tobacco smoking is a significant public health problem, and remains the leading cause of 
preventable, premature death in the UK. In order to reduce the burden of smoking in the UK, all 
healthcare professionals should be able to advise and assist smokers to quit. Adequately trained 
pharmacists can play a key role in providing smoking cessation support and advice. The aim was to 
identify the extent of smoking cessation teaching and examination in UK pharmacy schools. 
Methods: A short survey of smoking cessation was sent to each Programme Director for all UK 
pharmacy schools (n=29).   
Results: The survey achieved a response rate of 72%. All schools dedicated time teaching smoking 
cessation interventions, with 76% spending more than three hours, and 90% examining students on 
some aspect of smoking cessation. All schools taught about Nicotine Replacement Therapy (NRT) and 
the role of behavioural support. At least 90% of schools taught about the role of the stop smoking 
services; and opportunistic brief interventions, e.g. Very Brief Advice (VBA). Only 14% covered practical 
delivery in clinical settings. 
Conclusions: UK pharmacy schools are teaching and examining students on a wide range of smoking 
cessation interventions, including VBA. However, there was a lack of training reported on the 
management of mental health patients who smoke, and practical skills training. All schools should do 
more to ensure they are providing practical skills training to enable students to be adequately prepared 
for delivering smoking cessation support to all smokers, including vulnerable populations. 
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A survey of smoking cessation training within UK Pharmacy education 
Introduction  
Tobacco smoking is a significant public health problem, and remains the leading cause of preventable, 
premature death in the UK.1 Approximately 1 in 5 UK adults are still smoking.2 The risk of smoking-
related morbidity and mortality is substantially reduced when quitting smoking.3 Intervening to help all 
smokers quit thus has major potential to improve current and future health of all patients who use the 
National Health Service (NHS) services (a publicly funded national healthcare system in the United 
Kingdom).  
Smoking cessation is a priority area for health promotion. Smoking cessation interventions are 
amongst the most clinically and cost effective interventions available in healthcare.4 5 It is known that 
opportunistic brief advice from a health professional can be one of the most important triggers for a quit 
attempt6. Brief opportunistic interventions such as very brief advice (VBA)7 was developed to encourage 
smokers to take up a supported quit attempt. VBA consists of the three A’s: Ask (and record smoking 
status); Advise (on the best way of quitting); Act (on patient response). VBA can be delivered by any 
healthcare professional who interacts with a smoker, and was designed to encourage smokers to take 
up a supported quit attempt, with a range of treatment options and intensive behavioural support. The 
referral of smokers to effective, evidence-based stop smoking services is a vital part of ensuring that 
these individuals access the most effective method of stopping smoking.8 9 
Every encounter between a healthcare professional (HCP) and a patient who smokes is an 
opportunity to provide tobacco cessation advice, ideally by delivering detailed advice and support but, 
at the very least, to spend the less than 30 seconds necessary to deliver VBA. In order to reduce the 
burden of smoking in the UK, all healthcare professionals should be able to advise and assist smokers 
to quit.10 The Royal College of Physicians recently recommended that training in smoking cessation 
should be mandatory for all undergraduate and postgraduate healthcare professional training curricula, 
including pharmacy.11 Community pharmacy is increasingly recognised by the government as an 
effective mean for delivering public health initiatives. Pharmacists are respected healthcare 
professionals, and are often much more accessible and potentially more cost-effective than general 
practitioners.12 Pharmacists are ideally placed to support smokers wanting to quit. In the UK there are 
guidelines available for pharmacists about how to help smokers quit smoking.13 Community 
pharmacists are expected to provide advice on healthy lifestyles (including quitting smoking); to direct 
 
 
smokers to appropriate support, advice or treatment; and to provide community-based smoking 
cessation treatment as part of the local NHS stop smoking service13. There have been several studies 
showing that appropriately trained community pharmacists can make a significant contribution to 
smoking cessation.14 15 
There are currently no studies of smoking cessation training in UK pharmacy school curricula. It is 
important to assess what is being covered within the pharmacy school curricula to identify potential 
gaps in training. The present study aimed to identify which smoking cessation interventions are being 
taught, specific content areas assessed and the total number of hours dedicated to smoking cessation 
teaching in UK pharmacy schools.  
 
Method 
Sample and recruitment 
All UK Pharmacy schools with an accredited undergraduate programme (n=29) were invited to take 
part. A suitable staff member (e.g. Programme Director) from each Pharmacy school was identified, 
either personally (by CA), or via accessing the School’s website to determine the Programme lead. The 
staff member was responsible for the curriculum content and not necessarily responsible for teaching 
tobacco-related content. An email was sent containing an explanation of the study and a link to the 
survey. For non-responders, alternative staff members were identified from the schools website. Two 
reminders were sent.  
 
Materials: Questionnaire 
To identify the curricular coverage of smoking cessation in undergraduate pharmacy training 
programmes, we used a short questionnaire that was developed for the Royal College of Physicians to 
survey the curriculum content of UK Medical schools in relation to topics considered essential for 
medical practitioners to deliver evidence-based smoking cessation advice to their patients who 
smoked11. To encourage a higher response rate, the survey included only three compulsory questions 
and one follow-up question. Question 1 asked “Relating to smoking cessation interventions, does the 
content of your pharmacy school teaching include any of the following”:  Cost and clinical effectiveness; 
Opportunistic brief interventions e.g. very brief advice/the 3A’s: ask, advise, act; The role of behavioural 
support; The role of the stop smoking services; Nicotine Replacement Therapy; Varenicline; Bupropion; 
 
 
E-cigarettes; Practical delivery in class room settings (e.g. role play); Practical delivery in simulated 
settings ( e.g. with simulated patients); Practical delivery in clinical settings (e.g. observed a stop 
smoking practitioner in practice); Management of mental health patients who smoke; Management of 
pregnant smokers). Respondents could tick as many options as necessary. Question 2 asked: “The 
number of hours of teaching on smoking cessation interventions in your pharmacy school curriculum 
are”: <1 hour; 1-3 hours; 3-5 hours; >5 hours; do not know. Question 3 asked: “Are the students 
examined on smoking cessation interventions as part of the course?” yes; no; do not know.  If 
respondents answered yes to question 3 they were asked which topics (from question 1) the students 
were examined on.  
 
Procedure and analysis 
The survey tool ‘SurveyMonkey’ was used to host the survey (www.surveymonkey.com). A 
personalised email containing a link to the survey was sent to all identified respondents, with two follow 
up reminder emails sent to non-responders after 10 days each time. Consent to take part in the survey 
was implied by completion and submission of the questionnaire. After closure of the survey, all data 
were imported into excel. Statistical analyses involved computation of simple summary statistics to 
characterise the survey responses. Data were summarised using descriptive statistics (i.e. percentages 
(n) or mean, as appropriate.  
Ethical approval was not sought as the study was deemed to be an evaluation conducted solely to 
define and assess current smoking cessation training within pharmacy curricula in the UK. 
 
Results 
In total, 21 pharmacy schools responded to the survey, giving a response rate of 72%. Of the 13 
different interventions asked about in the survey, two were taught by all of the schools (NRT and The 
role of behavioural support), followed by The role of the Stop Smoking Services (n=20, 95%); 
Opportunistic brief interventions (n=19, 90%); Varenicline, and Practical delivery in class rooms, e.g. 
role play (n=16, 76%); E-cigarettes (n= 15, 71%); Bupropion (n=14, 67%); Practical delivery in simulated 
settings and Cost and clinical effectiveness (n=13, 62%). Half taught about the management of 
pregnant smokers (n=11, 52%), and only three (14%) taught about the management of mental health 
patients who smoke, and practical delivery in clinical settings. See Figure 1. 
 
 
 
INSERT FIGURE I 
 
The majority of the schools allocated 3-5 hours or more than 5 hours (n=16; 76%) teaching about 
smoking cessation. Nearly all of the schools reported examining the students on smoking cessation 
interventions (n=19; 90%). 
NRT was the topic students were most frequently examined on (n=20; 95%), followed by the role of 
behavioural support (n=17; 81%), opportunistic brief interventions, and the role of the stop smoking 
services (n=14; 67%). Half examined the students on practical delivery in simulated sessions (n=11, 
52%); cost and clinical effectiveness; and varenicline (n=10, 48%). Less than half of the pharmacy 
schools examined the students on bupropion or practical delivery in class room settings (n=9; 45%), 
management of pregnant smokers (n=8; 38%), E-cigarettes (n=7; 33%), management of mental health 
patients (n=2; 9%), and practical delivery in clinical settings (n=1; 5%).     
 
Discussion 
This is the first nationwide survey of smoking cessation interventions taught in undergraduate 
pharmacy curricula in the UK. The survey achieved a good response rate and the results demonstrate 
that all schools dedicate time teaching smoking cessation interventions, with 76% spending more than 
three hours, and 90% examining students on some aspect of smoking cessation. However, the number 
of different interventions taught varied by school.  
Our survey found that of the 13 topics on the survey, 11 were taught by at least half of the schools. It 
is very encouraging that all schools are teaching about NRT and the role of behavioural support; and 
at least 90% are teaching about the role of the stop smoking services, and opportunistic brief 
interventions, e.g. VBA. Examination of the topics was lower, with only five topics examined by at least 
half of the schools. Very few schools covered the practical delivery in clinical settings. Similar previous 
surveys of UK medical,11 16 nursing,17 and optometry18 schools have also shown there is a tendency to 
teach about the theoretical aspects of smoking cessation, but less so on practical skills training (e.g. 
practical skills training in clinical or simulated settings). Studies within pharmacy schools outside of the 
UK, e.g. US;19 Malaysia20 and the Middle East21 have also found a tendency to teach about theory and 
 
 
principles of addiction, with less attention on delivery of tobacco cessation interventions, and very few 
schools using role play or practical skills as part of assessment.  
The lack of practical skills training in clinical settings is a concern because pharmacy students may 
not be adequately prepared to deliver smoking cessation interventions once they are qualified. A lack 
of practical skills training among nurses has been shown to negatively impact how they deliver smoking 
cessation advice to patients.22 Greenhalgh and colleagues23 recent review of pharmacist led smoking 
cessation support found strong evidence that a lack of training is one of the major barriers to delivering 
smoking cessation support, but those who have been adequately trained are more likely to deliver it, 
spend longer on it and adhere to evidence-based standards than those who receive no training. 
Another concern is the significant lack of teaching about smoking cessation in mental health patients. 
Cessation causes a significant reduction in the metabolism of many psychiatric medications which 
means their doses should be reduced.24 The Royal College of Psychiatrists produced a guide on 
smoking and mental disorders25 which is endorsed by the Royal Pharmaceutical Society, and states 
that pharmacists have a key role in improving access to smoking cessation and reduction interventions 
for smokers with a mental disorder as well as facilitating appropriate changes of medication doses. A 
reduction in psychotropic medication following smoking cessation would save the NHS £40m a year,26 
as well as potentially reducing the incidence of adverse drug events. Given that previous surveys of 
medical schools11 16 have found a lack of teaching about the management of patients with mental health 
conditions who smoke, it is even more important that pharmacists, as medication experts, receive this 
training.  
There was also a lack of teaching about the management of pregnant patients who smoke, with only 
half of the pharmacy schools teaching about this. Cigarette smoking is the most important preventable 
cause of adverse pregnancy outcomes27 however it has been identified that most health professionals 
receive limited training in treating pregnant smokers.11 Midwives have also reported a lack of training 
on how to address smoking in pregnancy.28 It is essential that health care professionals who have 
contact with pregnant smokers, are appropriately trained to offer smoking cessation support, and this 
must also include community pharmacists.  
Although pharmacy schools generally recognise the importance of teaching smoking cessation, 
several studies have suggested there are a number of barriers to enhancing tobacco training. Studies 
of pharmacy schools outside of the UK19 21 have found the main barriers are lack of time within an 
 
 
already crowded curriculum; lack of staff expertise to teach about tobacco; and perceived lack of priority 
of tobacco related content. Within the UK, perceived barriers for delivery smoking cessation training in 
medicine,16 nursing17 and optomotery18 also include lack of time, and lack of staff knowledge. Pharmacy 
schools in the UK will therefore need to work on circumventing these barriers.  
Although our survey achieved a good response rate of 72%, there is the potential for selection bias 
that may have impacted the results. It is possible that schools responding to the survey were more likely 
to be engaged in smoking cessation and allocate more hours of instruction to tobacco-related content. 
There are also several other limitations. The results may be subject to recall bias, or social desirability, 
whereby participants over-reported the extent of smoking cessation training. It is also possible that the 
person completing the survey was not the most suitable and they may not have been knowledgeable 
or fully aware about all parts of the teaching being delivered in their school. Additionally the survey does 
not take into account the quality or delivery of teaching or the resources used, and this is likely to vary 
between schools.   
 
Conclusions 
Smoking remains a public health priority1 and the potential for community pharmacists to play a key 
role in providing smoking cessation support has been recognised. However, it is important that they are 
adequately trained and prepared to deliver evidence-based smoking cessation interventions. Our 
survey found that UK pharmacy schools are teaching and examining students on a wide range of 
smoking cessation interventions, including VBA. However, all schools should do more to ensure they 
are providing practical skills training to enable students to be adequately prepared for delivering 
smoking cessation support. Furthermore, there is very little attention given to the management of 
pregnant smokers and mental health patients who smoke. It is essential that pharmacists are also well 
equipped to also provide smoking cessation support to these vulnerable populations. Future studies 
may want to consider conducting a national survey of community pharmacists to identify and prioritise 
training needs (e.g. who to train, and in what and where, and how to deliver training). Other studies 
could explore newly qualified pharmacists about their comfort level with providing smoking cessation 
interventions.    
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